Back

A novel, Pillar-GDMT score for prediction of all-cause mortality in patients with heart failure with reduced ejection fraction requiring heart failure hospitalisation

1 September 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Pharmacotherapy for heart failure (1) Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Balazs Muk

Gottsegen National Cardiovascular Center, Budapest (Hungary)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Mr E. Boada Lincango (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Doctor P. Amornritvanich (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Doctor A. Urbinati (New York, US)
Abstract Slides
Presentation thumbnail
Doctor F. Banfi-Bacsardi (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Pharmacotherapy for heart failure (1)

The Event

Event poster

ESC Congress 2025

1 September 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
The implementation of modern guideline-directed medical therapy among hospitalized patients with heart failure with reduced ejection fraction: real-world experience from two tertiary cardiac centers
thumbnail
Congress Presentation
Four pillars of HFrEF: pilot study with real-world data
thumbnail
Congress Presentation
Validating the association between a composite metric of guideline-directed medical therapy (GDMT) and clinical outcomes for patients with heart failure with reduced ejection fraction (HFrEF)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources